Differential expression of multiple genes in association with MADH4/DPC4/SMAD4 inactivation in pancreatic cancer.
The Gene Logic Inc. Gene Express(R) tools and Affymetrix GeneChip(R) arrays were utilized to discover genes differentially expressed in pancreatic cancers with MADH4/DPC4/SMAD4 gene inactivation. cDNA was prepared from thirteen pancreas cancer cell lines with known MADH4 status (5 with wild-type MADH4 and 8 with inactivated MADH4) and hybridized to the complete Affymetrix Human Genome U133 GeneChip(R) set (arrays U133 A,B) for simultaneous analysis of 45,000 gene fragments corresponding to 33,000 known genes. 25 known genes were identified as down-regulated at least three fold in the MADH4 mutant cancer cell lines. 9 were decreased in expression at least 5 fold, and 1 in particular (ID3) was decreased 23 fold. Only 2 of the 25 down-regulated genes (ID1 and ID3) have been previously reported as MADH4-dependent targets, and the remaining 23 genes represent potential novel direct or indirect MADH4 downstream targets. Immunolabeling for Id1 and Id3 did not show a relationship with known MADH4 status in pancreatic cancer tissues, suggesting additional regulation of these two genes than activation by MadH4. Further investigations to validate and to determine the significance of these candidate target genes in pancreatic carcinogenesis and progression are warranted.
Cao
Dengfeng
D
Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, The Johns Hopkins Hospital Baltimore, MD, USA.
Ashfaq
Raheela
R
Goggins
Michael G
MG
Hruban
Ralph H
RH
Kern
Scott E
SE
Iacobuzio-Donahue
Christine A
CA
Curr Genet. 2005 Jan;47(1):1-17
15565322
Oncogene. 2001 Dec 20;20(58):8317-25
11840324
Cancer Res. 1996 Feb 1;56(3):490-4
8564959
Cancer Res. 2000 Mar 1;60(5):1332-40
10728695
Circulation. 2002 May 21;105(20):2423-8
12021231
Mol Cell Biol. 1997 Oct;17(10):5888-96
9315646
Am J Pathol. 1999 Sep;155(3):815-22
10487839
Genes Cells. 2002 Sep;7(9):949-60
12296825
Carcinogenesis. 2004 Apr;25(4):517-25
14688027
Gastroenterology. 2001 Sep;121(3):657-67
11522750
Gene. 2001 Mar 7;265(1-2):87-93
11255011
BMC Cancer. 2007 Nov 12;7:209
17997817
Annu Rev Genomics Hum Genet. 2003;4:237-56
14527303
Cancer Res. 1996 Jun 1;56(11):2527-30
8653691
Cancer Res. 2000 Nov 1;60(21):5929-33
11085505
Mol Cell Biol Res Commun. 1999 Jul;2(1):47-52
10527891
Cancer Res. 2000 Jun 15;60(12):3137-42
10866300
J Biol Chem. 2002 Feb 1;277(5):3176-85
11700304
Nat Rev Mol Cell Biol. 2007 Dec;8(12):970-82
18000526
Mol Cell Biol. 1993 Dec;13(12):7874-80
8247002
Cancer Res. 1997 Sep 15;57(18):3929-34
9307274
Int J Biochem Cell Biol. 2002 Jun;34(6):588-93
11943589
Proc Natl Acad Sci U S A. 2000 Aug 15;97(17):9624-9
10944227
Cancer Biol Ther. 2003 Mar-Apr;2(2):164-70
12750556
Nucleic Acids Res. 2000 Jun 15;28(12):2363-8
10871368
Science. 1996 Jan 19;271(5247):350-3
8553070
Carcinogenesis. 2007 Nov;28(11):2313-20
17638919
Oncogene. 2003 Jul 17;22(29):4498-508
12881706
Cancer Res. 2001 Dec 15;61(24):8803-10
11751402
Am J Pathol. 2002 Nov;161(5):1541-7
12414502
Trends Cell Biol. 2003 Aug;13(8):410-8
12888293
Clin Cancer Res. 2001 Dec;7(12):4115-21
11751510
Clin Cancer Res. 2002 Nov;8(11):3628-38
12429655
J Biol Chem. 2000 Sep 8;275(36):27501-4
10908559